CLINICO-PATHOLOGICAL PRESENTATION AND THERAPEUTIC OPTIONS FOR HAIRY CELL LEUKEMIA
Article Sidebar
Keywords:
Hairy cell leukemia (HCL), clinical presentation, treatment, interferon, cladribine, Pakistan
Main Article Content
Abstract
Objective: To look at clinical and hematological presentation as well as treatment outcome of patients with
diagnosis of Hairy Cell Leukemia (HCL) in our population.
Methodology: All patients diagnosed with HCL by morphological and immunohistochemical methods
presenting to Medical Oncology Ward at Hayatabad Medical Complex, Peshawar since August 2008 were
included in the study.
Results: Out of 7 patients diagnosed with HCL, 6 were male and 1 was female (M:F ratio 6:1). Median
age at diagnosis was 44 years. Fever, pallor, palpitations and fatigue were the commonest presenting
complaints. Spleenomegaly was noted in all patients (100%). Pancytopenia was noted in all patients at
presentation. Five patients were treated with Interferon while 2 were treated with Cladribine. At 18 months
of follow-up, one out five patients treated with IFN had relapse while both the patients treated with
Cladribine were in complete remission.
Conclusion: Our study showed that HCL patients present at a younger age in our region but further
studies with larger sample size are required to confirm this. All patients showed a complete response to
Interferon and Cladribine with all patients alive at 18 months of follow-up.
diagnosis of Hairy Cell Leukemia (HCL) in our population.
Methodology: All patients diagnosed with HCL by morphological and immunohistochemical methods
presenting to Medical Oncology Ward at Hayatabad Medical Complex, Peshawar since August 2008 were
included in the study.
Results: Out of 7 patients diagnosed with HCL, 6 were male and 1 was female (M:F ratio 6:1). Median
age at diagnosis was 44 years. Fever, pallor, palpitations and fatigue were the commonest presenting
complaints. Spleenomegaly was noted in all patients (100%). Pancytopenia was noted in all patients at
presentation. Five patients were treated with Interferon while 2 were treated with Cladribine. At 18 months
of follow-up, one out five patients treated with IFN had relapse while both the patients treated with
Cladribine were in complete remission.
Conclusion: Our study showed that HCL patients present at a younger age in our region but further
studies with larger sample size are required to confirm this. All patients showed a complete response to
Interferon and Cladribine with all patients alive at 18 months of follow-up.
Article Details
How to Cite
1.
Jameel A, Chiragh S, Iqbal S, Farooq M. CLINICO-PATHOLOGICAL PRESENTATION AND THERAPEUTIC OPTIONS FOR HAIRY CELL LEUKEMIA. J Postgrad Med Inst [Internet]. 2012 Jun. 29 [cited 2024 Nov. 18];26(3). Available from: https://jpmi.org.pk/index.php/jpmi/article/view/1309
Issue
Section
Short Communication
Work published in JPMI is licensed under a
Creative Commons Attribution-NonCommercial 2.0 Generic License.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.